tech titans in pharma

$1T+ opportunity.
Every single unicorn. Cigna x DTx.

January 21, 2023

Hi there,

Here are this week's top research briefs.

ICYMI

The Big Tech in Pharma Report: How Amazon, Microsoft, Apple, and Alphabet are capitalizing on digital transformation
Big tech is going after the $1T+ pharma market. Here’s how the tech titans are working to establish permanent places for themselves in the space through product launches, partnerships, M&A deals, and more.

11 Tech Trends To Watch Closely in 2023
Proliferating super apps. Immortality-as-a-service. The rise of consumer robots. Smell goes digital. Here are the top tech trends poised to reshape industries in 2023.

State of Fintech 2022 Report
Global fintech investment activity steadily declined throughout 2022, with funding dropping by 46% from 2021's record levels.

$1B+ Market Map: The world’s 1,205 unicorn companies in one infographic
In the wake of the market downturn, new unicorns have become increasingly rare. Our market map visualizes the 1,205 private companies worth $1B+ across artificial intelligence, e-commerce, fintech, and more.

Client-Exclusive Research

Unbundling Disney: How technology is reshaping the entertainment industry
Disney’s name is nearly synonymous with entertainment, but new technologies could radically change how movies and video games are created and delivered. From immersive hardware to synthetic speech, here are the tech solutions moving the industry forward.

Stripe, HubSpot, and JP Morgan are buying audiences. Why acquiring media companies and communities is about to explode
Instead of renting an audience, companies are realizing that owning their audiences and going direct can lower CAC and increase LTV. Here are our predictions for the media companies that technology and financial services companies should have on their M&A radar.

Source: @dharmesh

What are Cigna and Elevance Health doing in digital therapeutics?
As payers look for innovative ways to improve care at a lower cost, Cigna and Elevance Health (formerly Anthem) are exploring opportunities in digital therapeutics.

Have a great weekend.

I love you.

Anand
@asanwal

P.S. Hey, B2B startups. We know talking to your competitors' customers isn't easy. But don't worry, we'll do it for you — just reach out right here.

Get started with CB Insights.

Start Your Free Trial

CB Insights' emerging technology insights platform provides all the analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech.

Send to a friend

About Us | Update Preferences | Unsubscribe | Research | Newsletter